CRISPR Therapeutics AG
NASDAQ:CRSP
CRISPR Therapeutics AG
Total Other Income
CRISPR Therapeutics AG
Total Other Income Peer Comparison
Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors
Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Total Other Income
$83.8m
|
CAGR 3-Years
171%
|
CAGR 5-Years
284%
|
CAGR 10-Years
N/A
|
|
ADC Therapeutics SA
NYSE:ADCT
|
Total Other Income
$5.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
AC Immune SA
NASDAQ:ACIU
|
Total Other Income
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Total Other Income
CHf768k
|
CAGR 3-Years
-17%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Idorsia Ltd
SIX:IDIA
|
Total Other Income
-CHf5m
|
CAGR 3-Years
44%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
Kuros Biosciences AG
SIX:KURN
|
Total Other Income
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is CRISPR Therapeutics AG's Total Other Income?
Total Other Income
83.8m
USD
Based on the financial report for Mar 31, 2024, CRISPR Therapeutics AG's Total Other Income amounts to 83.8m USD.
What is CRISPR Therapeutics AG's Total Other Income growth rate?
Total Other Income CAGR 5Y
284%
Over the last year, the Total Other Income growth was 139%. The average annual Total Other Income growth rates for CRISPR Therapeutics AG have been 171% over the past three years , 284% over the past five years .